Name: Receivables Turnover

Definition: Receivables turnover tells you how quickly the company collects payments from customers after making sales on credit. A high turnover means customers pay on time and cash flows smoothly. Slow turnover suggests delayed collections, which can create cash shortages and financing stress.

Interpretation:
• In '2021', ICLR's receivables turnover was 2.64, showing efficiency in collecting outstanding receivables. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2021' stood at 3.19.
• In '2022', ICLR's receivables turnover was 3.18, showing efficiency in collecting outstanding receivables. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2022' stood at 3.95. Industry average increased by 0.76 compared to previous year.
• In '2023', ICLR's receivables turnover was 2.85, showing efficiency in collecting outstanding receivables. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2023' stood at 4.44. Industry average increased by 0.48 compared to previous year.
• In '2024', ICLR's receivables turnover was 2.88, showing efficiency in collecting outstanding receivables. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2024' stood at 5.65. Industry average increased by 1.21 compared to previous year.
Overall, ICLR's receivables turnover has steadily improved over the past 4 years.

Formula: Receivables Turnover = Net Credit Sales / Average Accounts Receivable

Good Range: Ranges 5 to 15 depending on credit terms.